syngo.MR Tissue4D

With motion corrected dynamic series and pharmacokinetic models, syngo.MR Tissue4D provides a powerful tool to gain additional functional information regarding tumors. By supporting the analysis of the enhancement curve, the application reveals information on the vascularization and permeability of tumors.

  • User defined automation
  • The same process for every scan
  • Significantly less user interaction

Caratteristiche e vantaggi

Features:

Supports two models:

  • The Tofts model (k-trans, kep, Ve and AUC)
  • A qualitative model ( wash-in, wash-out, peak enhancement, arrival time and time to peak) 

Performs the following functions automatically (based on the user’s input):

  • Motion correction of dynamic series: choice of reference volume; registration of all volumes to the reference volume
  • Alignment of pre-contrast and morphology to dynamic reference 
  • Pharmacokinetic modeling: definition of evaluation volume; choice of model and it’s parameters; computation of parametric maps according to the model

 

Benefits:

  • Provides additional functional information regarding tumors
  • Supports the analysis of the enhancement curve, thereby revealing information on the vascularization and permeability of tumors
  • Can be dropped “ad hoc” into other oncology workflows in order to complete the lesion analysis
  • Pre-processing is the heart of this application, set your preferred settings once and then read, quantify and report every case the same way. This user defined automation significantly reduces user interaction. 

General Requirements

  • syngo.via for MRI
  • MAGNETOM Vida

syngo.via VA20B

Please Note: Additional technical pre-requisites may apply. Upon receiving your request, your local Siemens representative will clarify whether your system meets the requirements.